Orbactiv 70842-0140

Generic: Oritavancin

Product NDC

70842-0140

Manufacturer: Melinta Therapeutics, Llc
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: September 1, 2014
Listing Expires: December 31, 2026
Application: NDA206334

Need to source Orbactiv? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Oritavancin	400 mg/1

Drug Class

Lipoglycopeptide Antibacterial [EPC]Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]

Packaging Options(1)

70842-0140-03

3 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01)

View →